Literature DB >> 12175462

Pretreatment with methylphenidate sensitizes rats to the reinforcing effects of cocaine.

Susan Schenk1, Sari Izenwasser.   

Abstract

Repeated administration of cocaine produces sensitization to its locomotor-activating effects and increases the rate at which cocaine self-administration behavior is acquired. Methylphenidate is administered clinically on a daily basis, predominantly to children and adolescents, for the treatment of attention-deficit hyperactivity disorder (ADHD). It has been demonstrated previously that pretreatment with methylphenidate administered to periadolescent rats decreased the latency to acquisition of cocaine self-administration. Since methylphenidate is often also administered to adults with ADHD, the present study was conducted to determine the effects of prior administration of methylphenidate (5 or 20 mg/kg/day for 9 days) to adult rats on the rate of acquisition for cocaine self-administration (0.25 mg/kg/infusion). The higher dose of methylphenidate significantly decreased the latency for acquisition of this behavior, suggesting that the rats were sensitized to the reinforcing effects of cocaine after treatment with methylphenidate. These findings add to the growing body of evidence suggesting cross-sensitization between the behavioral effects of psychostimulants. Further, insofar as self-administration is a reliable measure of abuse liability, these data suggest that a short-duration pretreatment with a high dose of methylphenidate to adults increases vulnerability to cocaine abuse.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12175462     DOI: 10.1016/s0091-3057(02)00735-9

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  20 in total

1.  Chronic psychostimulant exposure to adult, but not periadolescent rats reduces subsequent morphine antinociception.

Authors:  Michelle C Cyr; Susan L Ingram; Sue A Aicher; Michael M Morgan
Journal:  Pharmacol Biochem Behav       Date:  2012-03-03       Impact factor: 3.533

Review 2.  Neurobiological processes in adolescent addictive disorders.

Authors:  Ty S Schepis; Bryon Adinoff; Uma Rao
Journal:  Am J Addict       Date:  2008 Jan-Feb

3.  Nucleus accumbens lesions modulate the effects of methylphenidate.

Authors:  Adam Podet; Min J Lee; Alan C Swann; Nachum Dafny
Journal:  Brain Res Bull       Date:  2010-05-12       Impact factor: 4.077

4.  Low dose nicotine treatment during early adolescence increases subsequent cocaine reward.

Authors:  Susan C McQuown; James D Belluzzi; Frances M Leslie
Journal:  Neurotoxicol Teratol       Date:  2006-12-14       Impact factor: 3.763

5.  Chronic treatment with extended release methylphenidate does not alter dopamine systems or increase vulnerability for cocaine self-administration: a study in nonhuman primates.

Authors:  Kathryn E Gill; Peter J Pierre; James Daunais; Allyson J Bennett; Susan Martelle; H Donald Gage; James M Swanson; Michael A Nader; Linda J Porrino
Journal:  Neuropsychopharmacology       Date:  2012-07-18       Impact factor: 7.853

6.  H3 receptor blockade by thioperamide enhances cognition in rats without inducing locomotor sensitization.

Authors:  Victoria A Komater; Kaitlin E Browman; Peter Curzon; Arthur A Hancock; Michael W Decker; Gerard B Fox
Journal:  Psychopharmacology (Berl)       Date:  2003-04-08       Impact factor: 4.530

7.  Repeated administration of methylphenidate in young, adolescent, and mature rats affects the response to cocaine later in adulthood.

Authors:  Annelyn Torres-Reverón; Diana L Dow-Edwards
Journal:  Psychopharmacology (Berl)       Date:  2005-10-15       Impact factor: 4.530

8.  Potentiated gene regulation by methylphenidate plus fluoxetine treatment: Long-term gene blunting (Zif268, Homer1a) and behavioral correlates.

Authors:  Joel A Beverley; Cassandra Piekarski; Vincent Van Waes; Heinz Steiner
Journal:  Basal Ganglia       Date:  2014-12-01

9.  Cocaine-seeking behavior in a genetic model of attention-deficit/hyperactivity disorder following adolescent methylphenidate or atomoxetine treatments.

Authors:  Chloe J Jordan; Roxann C Harvey; Britahny B Baskin; Linda P Dwoskin; Kathleen M Kantak
Journal:  Drug Alcohol Depend       Date:  2014-04-28       Impact factor: 4.492

10.  Juvenile methylphenidate exposure and factors that influence incentive processing.

Authors:  Heather C Brenhouse; Lee Napierata; Lucinda Kussmaul; Melanie Leussis; Susan L Andersen
Journal:  Dev Neurosci       Date:  2009-04-17       Impact factor: 2.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.